Biodesix Anticipates Strong Preliminary Fourth Quarter 2020 Revenue (unaudited)
Press release content from Business Wire. The AP news staff was not involved in its creation. Biodesix Anticipates Strong Preliminary Fourth Quarter 2020 Revenue (unaudited) January 8, 2021 GMT BOULDER, Colo.--(BUSINESS WIRE)--Jan 8, 2021-- Biodesix, Inc. a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the company expects to report record fourth quarter 2020 preliminary unaudited revenue in a range of $25 million to $27 million. The strength in the fourth quarter 2020 was a result of growth in the company’s COVID-19 testing services, lun...